Related Experiment Video

Updated: Jun 5, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

Proximal atherosclerotic lesion as a cause of very late stent thrombosis

Sainath Gaddam1, Muniba Rizvi, Krishna Chaitanya Nimmagadda

  • 1Department of Internal Medicine, Staten Island University Hospital, New York, United States. gaddamsainath@gmail.com

Medical Hypotheses
|December 28, 2010
PubMed

Insights

Very late stent thrombosis, occurring over a year after coronary artery stent placement, may be caused by new atherosclerotic lesions. These lesions can impede blood flow and create a prothrombotic state, leading to thrombosis.

Area of Science:

  • Cardiology
  • Vascular Biology
  • Medical Device Research

Background:

  • Very late stent thrombosis (VLST) is a serious complication occurring >1 year after coronary stent implantation.
  • Drug-eluting stents (DES) have faced scrutiny due to reported increases in VLST.
  • The precise mechanisms underlying VLST remain incompletely understood.

Purpose of the Study:

  • To propose a novel hypothesis for the etiology of very late stent thrombosis.
  • To investigate the role of de novo atherosclerotic lesions in VLST development.
  • To link the natural progression of atherosclerosis to stent thrombosis risk.

Main Methods:

  • Literature review and theoretical modeling based on Virchow's triad.
  • Analysis of blood flow dynamics and endothelial environment.
  • Hypothesizing the impact of proximal de novo lesions on distal stent patency.

Main Results:

  • Proposed that de novo atherosclerotic lesions proximal to stents cause distal blood flow stasis.
  • Hypothesized that these lesions induce myocardial ischemia, creating a prothrombotic milieu.
  • Linked stasis and prothrombotic conditions to the formation of very late stent thrombosis.

Conclusions:

  • De novo atherosclerotic lesion formation in the proximal stented artery segment is a potential cause of VLST.
  • The aging process of atherosclerosis may predispose individuals to VLST through proximal lesion development.
  • Understanding this mechanism could inform future prevention and treatment strategies for VLST.

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...